baber/WOPTO huggingface dataset:
Patent NZ-194906-A (NZ)
Title: Secondary electric cell with non-aqueous electrolyte
Inventor: BREC R
IPC: H01M6/14
Filed: 1980-09-10
Abstract: A secondary electric cell which includes: a non-aqueous electrolyte, a negative electrode whose active material includes at least one alkali metal in contact with the electrolyte, and a positive electrode whose active material is suitable for intercalating the active material of the negative electrode, wherein said positive electrode includes an active compound or solid solution whose general formula is MxX, RyX3 where: M is an element chosen from lead and tin; R is an element chosen from bismuth and antimony; and X is an element chosen from sulphur and selenium, with x having a value lying between 0 and 1 (inclusive), and y having a value lying between 0 and 2 (inclusive). Such cells may be used in watches or pacemakers.
Patent NZ-205306-A (NZ)
Title: Pasteurised human fibrinogen
Inventor: KUMPE G
IPC: A61L2/04
Filed: 1983-08-17
Abstract: 1. A process for the pasteurization of human fibrinogen in aqueous solution, where in the human fibrinogen contains calcium in a concentration of 1 to 37.8 X 10**3 g atoms/mole of human fibrinogen in aqueous solution, together with customary stabilizers and is then heated in a manner which is customary per se.
Patent NZ-213207-A (NZ)
Title: Forming shaped metal articles by pressing blank between mould and a diaphragm of plastically deformable metal
Inventor: BARNES A J
IPC: B21D22/00
Filed: 1985-08-23
Abstract: Metal articles are shaped by contacting a metal blank with a diaphragm of plastically deformable metal which may be superplastic aluminium and urging the diaphragm against the blank and against a mould so that the diaphragm and body are deformed. The mould may be male or female. Thin metal articles of complex shape may be made easily and cheaply.
Patent NZ-225037-A (NZ)
Title: Substituted heterocyclic derivatives and pharmaceutical compositions
Inventor: EDWARDS PHILIP NEIL
IPC: C07D249/08
Filed: 1988-06-15
Abstract: A (substituted-aralkyl)heterocyclic compound of the formula I <CHEM> wherein R<1> is an azido, carbamoyl, cyano, formyl, hydroxy or nitro radical, a 1-6C 1-hydroxyalkyl, alkoxy, alkylcarbamoyl, alkylthio, alkylsulphinyl or alkylsulphonyl radical, a 2- cyanoethyl radical, optionally bearing one to four 1-6C alkyl substituents, or a 2-6C alkanoyl, halogenoalkanoyl, alkanoyloxy, alkanoylamino, dialkylcarbamoyl or alkoxycarbonyl radical; R<2> and R<3>, which may be the same or different, are each a hydrogen atom, a 1-6C alkyl, deuterioalkyl or halogenoalkyl radical, or a phenyl or phenyl(1-6C alkyl) radical, in each of which the phenyl may optionally bear one or more substituents; or R<2> and R<3>, together with the carbon atom to which they are attached, may form a 3- to 6-membered ring; or R<1>R<2>R<3>C-is a 1,1-dicyanoethyl or trifluoromethylsulphonyl radical; R<4> is a hydrogen or halogen atom, a cyano or nitro radical or a 1-6C alkyl or halogenoalkyl radical; R<5> has any of the values defined above for the group R<1>R<2>R<3>C but is not necessarily the same as R<1>R<2>R<3>C, or has any of the values defined above for R<4> but is not necessarily the same as R<4>, or is a carbamoyl, 1-pyrrolidinyl-carbonyl, piperidinocarbonyl, morpholinocarbonyl or nitro radical, a 1-6C alkoxy or halogenoalkoxy radical or a 2-6C alkanoyl or alkoxy-carbonyl radical; A is a methylene or ethylene radical optionally bearing one or more substituents selected from deuterium and halogen atoms, carbamoyl, cyano and hydroxy radicals, 1-6C alkyl and alkoxy radicals, and 2-6C alkanoyloxy radicals provided that when A is linked to R<6> through a nitrogen atom thereof, it may not bear a hydroxy, alkoxy or alkanoyloxy substituent on the carbon atom adjacent to such nitrogen atoms; and R<6> is a 1H-1,2,4- triazol-1-yl, 4H-1,2,4-triazol-4-yl, 1H-imidazol-1-yl, 5-cyano-1H-imidazol-1-yl, 3-pyridyl or 5-pyrimidinyl radical, or a 1H-imidazol-1-yl radical, bearing at the 5-position thereof a 1-6C alkyl substituent which is itself optionally substituted by one or more carbamoyl, cyano, hydroxy or 2-6C alkoxycarbonyl radicals; and provided that when R<2>, R<3>, R<4> and R<5> are hydrogen, A is a methylene radical and R<6> is a 3-pyridyl radical, R<1> is not a cyano, hydroxy or hydroxymethyl radical, and when R<1> is a hydroxy radical, R<3>, R<4> and R<5> are hydrogen, A is a methylene radical and R<6> is 3-pyridyl, R<2> is not a methyl or a 2-chloro-1-methylethyl radical, and provided that when R<1> is a methoxycarbonyl radical, R<2>, R<3>, R<4> and R<5> are hydrogen and A is a methylene radical, R<1> is not a 1H-imidazol-1-yl radical; and the pharmaceutically acceptable acid addition salts thereof.
Patent NZ-226556-A (NZ)
Title: Mobile round hay baler with continuous operation: hay compacted in feed passage during tying of formed bale
Inventor: QUATAERT PETRUS MARIA
IPC: A01F15/07
Filed: 1988-10-12
Abstract: In the formation of tied rolled crop bales (R), the period of time between the closing of the tying means on the circumference of the rolled bale, the ejection of the rolled bale and the closing of the press chamber is critical, because the crop fed continuously in large quantities should not disrupt either the final tying or the ejection. With the new method and the apparatus suitable for carrying it out, a time buffer for this phase will be provided, without any appreciable outlay in terms of the construction of the apparatus. For this, intermediate storage is carried out in two steps one after the other, in the first step the crop also being compressed in the feed channel, and in the second step up to the closing of the press chamber the crop also being stored intermediately in the press chamber, each time being separated from the rolled bale. For this purpose, the apparatus has a press roller equipped with press blades and located in the feed channel, and a separating element (T) which, in a build-up position, can be moved with the crop (G) through the inlet (8) into the press chamber (4). 
<IMAGE>
Patent NZ-228871-A (NZ)
Title: 6-oxo-pyridazine derivatives and pharmaceutical compositions
Inventor: MORSDORF PETER
IPC: C07D401/14
Filed: 1989-04-24
Abstract: Novel 6-oxopyridazine derivatives of the general formula I 
<IMAGE>
 which are novel positively inotropic compounds which have a higher, more selective, inotropism-enhancing activity. 
<??>A preparation process and the pharmaceutical use of these substances or of a medicament containing these substances are also described.
Patent NZ-230901-A (NZ)
Title: Milk product acidified by fermentation having a creamy consistency
Inventor: HOSE HUGH
IPC: A23C9/123
Filed: 1989-10-04
Abstract: An acidified milk product of creamy consistency obtained by acidification of a suspension of the skimmed milk type with a combination of roping and thickening lactic bacteria and showing high stability to hot coffee, to sterilization and in storage.
Patent NZ-233856-A (NZ)
Title: Rotor for hay making apparatus having self-supporting resiliently
Inventor: SIELING NICOLAAS LAURISSE
IPC: A01D78/10
Filed: 1990-05-29
Abstract: PCT No. PCT/AU91/00231 Sec. 371 Date Nov. 25, 1992 Sec. 102(e) Date Nov. 25, 1992 PCT Filed May 29, 1991 PCT Pub. No. WO91/18497 PCT Pub. Date Dec. 12, 1991.A hay making apparatus includes a rotor carrying demountable rigid tynes spaced about its periphery and coupled to a drive motor, preferably a hydraulic type. The rotor has an annular body of a resiliently deformable elastomeric material advantageously having a cross-sectional shape similar to that of a tire for a motor vehicle with its longitudinal axis vertically oriented. The rotor has the following: an inwardly projecting upper wall which couples the annular body flexibly to the motor; an inwardly projecting lower wall which follows undulations in the ground surface; and a vertical wall in which passages are formed for seating the tynes. In use, the tynes are held in place solely by centrifugal force and by contact with the passage walls.
Patent NZ-235474-A (NZ)
Title: Virus capable of inducing infectious bursal disease; assay and vaccine
Inventor: SNYDER DAVID B
IPC: A21D2/36
Filed: 1990-09-26
Abstract: A new virus not neutralized or bound by monoclonal antibodies which are group neutralizing to all IBDV vaccines of current art, and capable of inducing infectious bursal disease in poultry is identified, in essentially pure form. A test kit, and assay for the presence of the virus is disclosed, together with the vaccine incorporating the virus.
Patent NZ-268769-A (NZ)
Title: Multi-layered tissue paper webs containing biodegradable softeners and binders
Inventor: PHAN DEAN VAN
IPC: D21H17/06
Filed: 1994-06-17
Abstract: Multi-layered tissue paper webs comprising chemical softener compositions and binder materials are disclosed. The multi-layered tissue webs are useful in the manufacture of soft, absorbent paper products such as facial tissues and/or toilet tissues. The multi-layered tissue paper products contain a chemical softening composition comprising a mixture of a quaternary ammonium compound and a polyhydroxy compound. Preferred quaternary ammonium compounds include dialkyl dimethyl ammonium salts such as di(hydrogenated)tallow dimethyl ammonium chloride, di(hydrogenated)tallow dimethyl ammonium methyl sulfate. Preferred polyhydroxy compounds are selected from the group consisting of glycerol, sorbitols, polyglycerols having a weight average molecular weight of from about 150 to about 800, polyoxyethylene glycols and polyoxypropylene glycols having a weight average molecular weight from about 200 to 4000. The multi-layered tissue paper webs also contain an effective amount of binder materials to control linting and/or to offset the loss in tensile strength, if any, resulting from the use of the chemical softening compositions. The binder materials are selected from the various wet and dry strength additives, and retention aids used in the paper making art. Preferably, the majority of the chemical softening compositions will be disposed on the outer layers of the multi-layered tissue paper products where they are most effective. The binder materials are typically dispersed throughout the multi-layered product to control linting. In other words, the chemical softening compositions and the binder materials can be selectively distributed within the multi-layered tissue paper web to enhance the softness, absorbency, and/or lint resistance of a particular layer or ply.
Patent NZ-280743-A (NZ)
Title: Topical composition comprising zinc phthalocyanine, -diethylene glycol monoalkylether, optionally a lipid and a gelling agent
Inventor: LOVE WILLIAM GUY
IPC: A61K41/00
Filed: 1995-12-21
Abstract: A topically administrable pharmaceutical composition comprising (A) zinc phthalocyanine, (B) as carrier for (A), (i) a monoalkyl ether of diethyleneglycol substantially in the absence of a N-alkylpyrrolidone, a N,N-dialkylbenzamide or dimethyl sulphoxide, or (ii) a mixture of a monoalkyl ether of diethyleneglycol with a lipid and (C) a gelling agent.
Patent NZ-298642-A (NZ)
Title: Computer management of financial accounts
Inventor: ATKINS CHARLES A
IPC: G06Q20/10
Filed: 1995-12-04
Abstract: A practical communication and computer based system and method for effecting exchange, investment and borrowing involves the use of digital communication and computation terminals distributed to users and service providers. Through the system described and its combined computer and communication terminals, client/customers may purchase goods and services, save, invest, track bonuses and rebates and effect enhanced personal financial analysis, planning, management and record keeping with less effort and increased convenience. Through a prioritization function, the client specifies her financial objectives, her risk preference, and budgetary constraints. The prioritization function automatically suggests to the individual a portfolio of asset and liability accounts that may be credited and/or debited to provide the required funds for consumption and to form investments and borrowing to best realize her financial objectives over a defined time horizon. If desired, the system automatically manages a client's budgetary and financial affairs through a system of expert sweeps based on a client's preferences. The client's accounts are monitored via a borrowing power baseline, and considered imbalanced if the client's borrowing power is less than the minimum borrowing power. If the account is imbalanced, the client may reallocate the assets and liabilities within the client account and/or modify a set of constraints on the client account. If the client account is still not balanced after modification of the account, the system will deny authorization for certain requested transactions, and may initiate the liquidation of certain asset accounts and reduce the balances of one or more liability accounts.
Patent NZ-302586-A (NZ)
Title: Isoxazole derivatives, preparation and pharmaceutical compositions thereof
Inventor: TALLEY JOHN J
IPC: A61P1/02
Filed: 1996-02-12
Abstract: A class of substituted isoxazolyl compounds is described for use in treating cyclooxygenase-2 related disorders. Compounds of particular interest are defined by Formula I    <IMAGE>  I  wherein R1, R2, and R3, are described in the specification.
Patent NZ-334388-A (NZ)
Title: Antenna assembly with an elongate tray and an elongate radome fixed at intermediate points
Inventor: THOMPSON JOHN HEYWOOD
IPC: H01Q1/42
Filed: 1999-02-26
Abstract: Elongate radome 3 is fixed to tray 2 at an intermediate portion 12,18 to permit differential expansion in use between radome and tray on both sides of the portion.
Patent NZ-500062-A (NZ)
Title: Woven wire netting for protection against rock falls or for securing a top layer of soil, and method and device for producing same
Inventor: EICHER BERNHARD
IPC: B21J15/02
Filed: 1999-02-02
Abstract: A wire netting (10), preferably used as a gravel screen or for protecting a soil surface layer is woven from corrosion -resistant wires (11,12,13,14) and either fitted on the soil surface or secured in an almost upright position on a slope or something similar.  The wires (11, 12, 13, 14) in the wire netting (10) are manufactured from heavy -duty steel, whereby the heavy-duty steel wire has a nominal strength of in the region of 1000 to 2200 N/mm2 and the steel wire may be used for this for standard wires or spring steel wire.  The wire netting is manufactured from rectangular, diagonal netting and it has a three-dimensional, mattress-like structure.
Patent NZ-500987-A (NZ)
Title: Fungicidal mixture comprising a phenyl benzyl ether and a carboxamide
Inventor: STRATHMANN SIEGFRIED
IPC: A01N37/50
Filed: 1998-05-18
Abstract: A fungicidal mixture comprising a phenyl benzyl ether derivative of the formula I.a, I.b or I.c and a carboxamide selected from the group IIa and IIb.
Patent NZ-502695-A (NZ)
Title: Method of replacing heart valves using flexible tubes of intestinal tissue
Inventor: COX JAMES L
IPC: A61L27/36
Filed: 1996-12-27
Abstract: This application comprises a method of using tubular material to replace a heart valve during cardiac surgery. To create a replacement atrioventricular (mitral or tricuspid) valve, the tube inlet is sutured to a valve annulus from which the native leaflets have been removed, and the tube outlet is sutured to papillary muscles in the ventricle. To create a semilunar (aortic or pulmonary) valve, the tube inlet  is sutured to an annulus from which thenative cusps have been removed, and the tube is either "tacked" at three points distally inside the artery, or sutured longitudinally along three lines; this allows the flaps of tissue between the three fixation points at the valve outlet to function as movable cusps.  These approaches generate flow patterns that closely duplicate the flow patterns of native valves. A preferred tubular material comprises submucosal tissue from the small intestine of the same patient who is undergoing the cardiac operation. By using tissue from the same patient, the risk of immune rejection and the need to treat or reduce antigenicity are eliminated. Animal or human cadaver intestinal tissue can also be used if properly treated, or a biocompatible synthetic tubular material can also be used.
Patent NZ-508780-A (NZ)
Title: Combination of scrabble and chinese checkers word construction board game
Inventor: DUNN ANDREW CARSON
IPC: A63F3/04
Filed: 2000-12-11
Abstract: In a word spelling board game, a variation of "scrabble", a first player starts from one side, say the south side of the board having an array of square spaces, and the second player starts from the other, north, side of the board, and each in turn progresses across the board constructing intersecting words on the spaces on the board with letter tiles from a pool of letter tiles belonging to each player, vertically and across until one player bridges the board with words to be the winner.  The tiles have respective upper and lower case letters on respective faces.  The words must be constructed so that each tile is adjacent two tiles except the first and last pieces that are each adjacent one other piece only. Each subsequent word added by a player during a turn must include the players own pieces and one playing piece of another player which is either a consonant or a vowel as determined by the players before commencement of play.
Patent NZ-511686-A (NZ)
Title: Automatic transmission for vehicles
Inventor: MORII MASARU
IPC: F16H3/74
Filed: 2000-09-20
Abstract: An automatic transmission includes an input first rotating member (3), an output second rotating member (6) coaxial with the first rotating member (3), a third rotating member (8) coaxial with the first rotating member (3), and a rotation transmitting element (10) mounted on the third rotating member (8) to transmit rotation of the first rotating member (3) to the second rotating member (6) so that the second rotating member (6) is rotated at a predetermined reduction ratio exceeding rotation of the first rotating member (3) in a stopped state of the third rotating member (8) in a direction of rotation of the first rotating member (3). The reduction ratio is increased as a difference between numbers of revolution of the first and third rotating members (3, 8) is rendered larger.
Patent NZ-512237-A (NZ)
Title: An infant simulator (doll) with a curved neck tube to simulate pivoting of head of a baby
Inventor: JURMAIN MARY M
IPC: A63H3/40
Filed: 1998-08-25
Abstract: The infant simulator comprises a doll having at least a torso and a head pivotably connected to the torso by a neck linkage, where the neck linkage includes: i) A first element fixedly attached to the head, ii) A second element fixedly attached to the torso and pivotably engaging the first element so as to permit pivoting of the head relative to the torso as between an acceptable aligned position and an unacceptable bent position. The point of pivoting engagement between the first and second elements is positioned within a gap between the head and torso when the head is positioned in the unacceptable bent position.
Patent NZ-514762-A (NZ)
Title: Polymorphs of crystalline (2-benzhydryl-1-azabicyclo[2.2.2]oct-3-yl)-(5-isopropyl-2-methoxybenzyl)-amine citrate as NK-1 receptor antagonists
Inventor: MASSETT STEPHEN SARGENT
IPC: C07D453/02
Filed: 2000-05-17
Abstract: The disclosed is directed to certain polymorphs and forms of crystalline (2-Benzhydryl-1-azo-bicyclo[2.2.2]oct-3-yl)-(5-isopropyl-2-methoxybenzyl)-amine citrate and their pharmaceutical composition.  The citrate salt is a CNS active NK-1 receptor antagonist and the disclosed is directed to methods of treating conditions affected or facilitated by a decrease in substance P mediated neurotransmission. Two crystalline polymorphic forms of (2-Benzhydryl-1-azo-bicyclo[2.2.2]oct-3-yl)-(5-isopropyl-2-methoxybenzyl)-amine citrate monohydrate (the monohydrates) are described. The pharmaceutical composition containing at least one of these polymorphs has advantageous stability for formulation to treat acute emesis in-patient receiving chemotherapy. The administration of this pharmaceutical composition is conventionally oral by preferably tablet or capsule and intravenous means.  Methods of making crystalline polymorphic are also disclosed.
Patent NZ-515561-A (NZ)
Title: Method for the production of thiazolidin
Inventor: DEMUTH HANS-ULRICH
IPC: C07D277/04
Filed: 2000-04-11
Abstract: A process for the production of thiazolidine which is characterized in that hexamethylenetetramine of formula (I) is caused to react with cysteamine of formula (II) in which X(-) represents an acid residue, X(-) being preferably a halide or sulphate.
Patent NZ-517048-A (NZ)
Title: Skin cleansing composition with improved stability comprising a surfactant, a silicone, a hydrocarbonaceous material, a cationic polymer, a polyacrylate thickening polymer, an acrylate/methacrylate copolymer and water
Inventor: HARMALKER SUBHASH
IPC: C11D17/00
Filed: 2000-08-18
Abstract: An aqueous composition comprising: i) At least 1 weight percent of a surfactant or mixture thereof. ii) A silicone in quantities of from 0.1 to 8 weight percent of the composition and having a minimum average particle size above 2 microns. iii) A hydrocarbonaceous material in quantities of from 0.1 to 8 weight percent of the composition. iv) A cationic polymer in quantities of from 0.02 to 1 weight percent of the composition. v) A combination of a polyacrylate thickening polymer and an acrylate/methacrylate copolymer wherein the ester group of the methacrylate is alkyl of 12 to 20 carbon atoms, the alkyl having 14 to 26 ethoxy groups and the acrylate is one or more monomers of acrylic acid, methacrylic acid or one of their simple esters in quantities sufficient to provide both viscosity and visual phase stabilization.  The polyacrylate is 0.5 to 2.0 weight percent of he composition and the acrylate methacrylate copolymer is 0.1 to 1.0 weight percent of the composition. vi) The balance water. Also described is an aqueous composition comprising: i) A skin cleansing amount of a surfactant or mixture thereof. ii) A silicone in quantities of from 0.1 to 8 weight percent of the composition. iii) A hydrocarbonaceous material in quantities of from 0.4 to 8 weight percent of the composition. iv) A cationic polymer in quantities of from 0.02 to 1 weight percent of the composition. v) A combination of a polyacrylate thickening polymer and an acrylate/methacrylate copolymer wherein the ester group of the methacrylate is alkyl of 12 to 20 carbon atoms, the alkyl having 14 to 26 ethoxy groups and the acrylate is one or more monomers of acrylic acid, methacrylic acid or one of their simple esters in quantities sufficient to provide both viscosity and visual phase stabilization. vi) The balance water.
Patent NZ-517803-A (NZ)
Title: Gluten substitutes comprising an aerated mass made by heating together a protein a fat a starch and a liquid
Inventor: UHLIK FRANK
IPC: A21D13/04
Filed: 2000-09-13
Abstract: A method is disclosed for producing a gluten substitute gum. The method comprises heating a mixture comprising a starch, an edible fat, an edible protein and a liquid for a time and under conditions sufficient to form an aerated mass. This aerated mass largely mimics gluten and may be used in combination with flours, whether gluten-free or otherwise, to form dough's for producing bakery products including breads cakes and pastries.
Patent NZ-518473-A (NZ)
Title: Methods of treating neurological disorders in a non-human animal
IPC: C07D207/06
Filed: 2002-04-19
Abstract: A method for affecting a neuronal activity in a non-human animal is described. The method comprises administering to the animal an effective amount of a compound that are neurotrophic low molecular weight, small molecule heterocyclic thioesters and ketones, and have an affinity for FKBP-type immunophilins. The compounds are used in medicaments to stimulate damaged neurons, promote neuronal regeneration, prevent neurodegeneration, and treat Alzheimer's Disease, Parkinson's Disease and amyotrophic lateral sclerosis. (62) Divided out of 507720